透析中的血压与容量管理:KDIGO争议会议结论
2019年2月KDIGO召开争议会议,评估透析患者血压与容量管理的知识现状。会议围绕血压测量、靶目标与药物管理、透析处方、细胞外容量评估及患者症状四大主题展开。核心结论是透析血压与容量管理需在狭窄治疗窗内权衡多重临床因素与患者偏好,个体化制定透析处方。
要点
- 透析血压与容量管理缺乏客观容量指标和高质量证据,共识形成困难。
- 管理需综合合并症、血流动力学模式、临床判断与患者偏好。
- 个体化透析处方是避免急慢性容量相关并发症的关键。
核心结论
- 透析中血压与容量管理需在狭窄治疗窗内权衡多重临床因素、风险及患者偏好,个体化制定透析处方。
研究设计与样本
- 2019年2月KDIGO举办的争议会议,评估透析血压与容量管理的知识现状并识别改善预后的机会。
主要发现
- 会议围绕血压测量、血压靶目标与药物管理、透析处方与血压容量关系、细胞外容量评估与管理及容量相关患者症状四大主题展开。
- presentations和讨论的总体主题是管理涉及权衡多个临床因素和风险考虑以及患者生活方式和偏好。
临床怎么用
- 将合并症、治疗血流动力学模式、临床判断和患者偏好纳入决策,在当地资源限制内个体化透析处方。
局限性
- 缺乏细胞外容量状态的客观测量方法。
- 许多治疗干预缺乏高质量证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Blood pressure (BP) and volume control are critical components of dialysis care and have substantial impacts on patient symptoms, quality of life, and cardiovascular complications. Yet, developing consensus best practices for BP and volume control have been challenging, given the absence of objective measures of extracellular volume status and the lack of high-quality evidence for many therapeutic interventions. In February of 2019, Kidney Disease: Improving Global Outcomes (KDIGO) held a Controversies Conference titled Blood Pressure and Volume Management in Dialysis to assess the current state of knowledge related to BP and volume management and identify opportunities to improve clinical and patient-reported outcomes among individuals receiving maintenance dialysis. Four major topics were addressed: BP measurement, BP targets, and pharmacologic management of suboptimal BP; dialysis prescriptions as they relate to BP and volume; extracellular volume assessment and management with a focus on technology-based solutions; and volume-related patient symptoms and experiences. The overarching theme resulting from presentations and discussions was that managing BP and volume in dialysis involves weighing multiple clinical factors and risk considerations as well as patient lifestyle and preferences, all within a narrow therapeutic window for avoiding acute or chronic volume-related complications. Striking this challenging balance requires individualizing the dialysis prescription by incorporating comorbid health conditions, treatment hemodynamic patterns, clinical judgment, and patient preferences into decision-making, all within local resource constraints.
引用
- Flythe JE, Chang TI, Gallagher MP, et al. Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020. PMID: 32278617. doi:10.1016/j.kint.2020.01.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。